JPS5690015A - Preventive and remedy containing human ceruloplasmin as main component - Google Patents
Preventive and remedy containing human ceruloplasmin as main componentInfo
- Publication number
- JPS5690015A JPS5690015A JP16755079A JP16755079A JPS5690015A JP S5690015 A JPS5690015 A JP S5690015A JP 16755079 A JP16755079 A JP 16755079A JP 16755079 A JP16755079 A JP 16755079A JP S5690015 A JPS5690015 A JP S5690015A
- Authority
- JP
- Japan
- Prior art keywords
- remedy
- containing human
- ceruloplasmin
- agents
- preventive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101000908019 Homo sapiens Ceruloplasmin Proteins 0.000 title abstract 4
- 230000003449 preventive effect Effects 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 5
- 230000000694 effects Effects 0.000 abstract 3
- 230000009876 antimalignant effect Effects 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 abstract 2
- 108010017384 Blood Proteins Proteins 0.000 abstract 1
- 102000004506 Blood Proteins Human genes 0.000 abstract 1
- 108010075016 Ceruloplasmin Proteins 0.000 abstract 1
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 abstract 1
- 229930192392 Mitomycin Natural products 0.000 abstract 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 abstract 1
- 229940100198 alkylating agent Drugs 0.000 abstract 1
- 239000002168 alkylating agent Substances 0.000 abstract 1
- 239000002256 antimetabolite Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229960004397 cyclophosphamide Drugs 0.000 abstract 1
- 208000013210 hematogenous Diseases 0.000 abstract 1
- 229960001428 mercaptopurine Drugs 0.000 abstract 1
- 229960004857 mitomycin Drugs 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16755079A JPS5690015A (en) | 1979-12-25 | 1979-12-25 | Preventive and remedy containing human ceruloplasmin as main component |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16755079A JPS5690015A (en) | 1979-12-25 | 1979-12-25 | Preventive and remedy containing human ceruloplasmin as main component |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5690015A true JPS5690015A (en) | 1981-07-21 |
| JPS623814B2 JPS623814B2 (enrdf_load_stackoverflow) | 1987-01-27 |
Family
ID=15851788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16755079A Granted JPS5690015A (en) | 1979-12-25 | 1979-12-25 | Preventive and remedy containing human ceruloplasmin as main component |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5690015A (enrdf_load_stackoverflow) |
-
1979
- 1979-12-25 JP JP16755079A patent/JPS5690015A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS623814B2 (enrdf_load_stackoverflow) | 1987-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8504967L (sv) | Farmaceutisk komposition och forfarande for behandling av kroppen | |
| EP0552256A4 (enrdf_load_stackoverflow) | ||
| ZA896287B (en) | Pharmaceutical combination preparations for use in anti-neoplastic therapy | |
| HU896762D0 (en) | Process for preparation of pyrimidine-derivatives and for manufacturing of pharmaceutical compositions containing these compounds | |
| EP0151989A3 (en) | Means for the treatment of cardiac diseases | |
| GR3006091T3 (enrdf_load_stackoverflow) | ||
| MY100900A (en) | Substituted phenylsulfonyloxybenzimidazolecarbamates, processes for their preparation and their use as medicaments. | |
| IL88971A0 (en) | Disubstituted pyridines,their preparation and pharmaceutical compositions containing them | |
| SE8102456L (sv) | Farmaceutisk komposition for oral administering och innehallande cytidindifosfokolin | |
| IL89662A0 (en) | Pharmaceutical compositions comprising interferon-beta 1 | |
| HUT68876A (en) | Pharmaceutical composition for treating tumours, containing creatine phosphate or phospho-enol-pyruvic acid | |
| JPS5767518A (en) | Radiosensitizing agent or agent for increasing effect of radiomimetic substance | |
| DE3263832D1 (en) | Gallium chloride, an anti-cancer drug | |
| ZA877901B (en) | Active compounds for use in the treatment of tumors | |
| JPS5690015A (en) | Preventive and remedy containing human ceruloplasmin as main component | |
| AU536582B2 (en) | Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends | |
| EP0476711A3 (en) | Use of 5-fluorouracil for the treatment of AIDS | |
| ZA884262B (en) | Pharmaceutical composition for the treatment of tumors | |
| DE3163920D1 (en) | Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases | |
| JPS55113721A (en) | Immunity regulator | |
| IL94621A0 (en) | Pharmaceutical compositions containing vitamin a in association with various therapeutically active ingredients | |
| EP0348664A3 (en) | Pharmaceutical compositions containing monoacetoacetins for treating tumours | |
| EP0335446A3 (en) | Agents for treating neoplasms | |
| IL107818A (en) | Pharmaceutical compositions for treating viral infections by conjunctive therapy with acylovir-like compounds and a 2'-(halo) methylene nucleoside analog | |
| JPS6438027A (en) | Remedy for cancer |